Bioinvent.
Swedish clinical-stage biotech company
- Reports this week
- 0
- Active events
- 2
- Connections
- 11
What's happening
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Bioinvent this week
News at the entities that move Bioinvent most-
FDA StructuralFDA approval supports NDA submission in Aurora.Moves Bioinvent
-
Merck KGaA OperationalNasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.Moves Bioinvent
-
European Society for Medical Oncology OperationalHengrui Pharma and Guangdong Provincial People's Hospital presented research findings at the ESMO Congress on October 20, 2026.Moves Bioinvent
-
Sweden Shared contextIndia and Sweden aim to double bilateral trade by 2030, with discussions held in Gothenburg.Moves Bioinvent
-
American Association for Cancer Research Mentioned togetherClimate-driven wildfire seasons are worsening, prompting efforts in Eugene to fund community resilience and address cancer risks from smoke exposure.Moves Bioinvent
-
Madrid Mentioned togetherAna Mena and India Martínez are hosting major music events in Madrid, expanding their brand presence into European markets.Moves Bioinvent
Connections
The 10 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA granted Fast Track Designation to Bioinvent for its BI-1808 program.
-
MSD Operational
MSD and Bioinvent are collaborating on a joint therapeutic effort combining MSD's anti-PD-1 therapy with Bioinvent's antibody.
-
Stefan Structural
Stefan Ericsson serves as the Chief Financial Officer of Bioinvent.
-
Merck KGaA Operational
Both companies are actively competing in the development of novel anti-TNFR2 antibodies.
-
Sweden Shared context
Bioinvent is headquartered in Lund, which is located within the borders of Sweden.
-
American Association for Cancer Research Mentioned together
Bioinvent published study results in the AACR journal.
-
European Society for Medical Oncology Operational
Bioinvent presented scientific data at the European Society for Medical Oncology Congress.
-
Abramson Cancer Center Operational
The entities are engaged in joint clinical research, evidenced by the presentation of Phase 2a trial data.